Drug Database · Clinicians

Hyoscine-n-butylbromide + Paracetamol

Also known as: butylscopolamine bromide (international nonproprietary name, for hyoscine-n-butylbromide) · acetaminophen (US name, for paracetamol)

Brands (13) Buscopan Plus, Butasine Plus, HNBBGEN Plus…Show all

Anticholinergic/Analgesic/Antipyretic; Analgesic/ anticholinergic; and others PH FDA category
Fixed-dose combination.

Rx · Prescription drugOTC · Over-the-counter13 PH products
Dispensing: Over-the-counter (OTC) · Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: Gastrointestinal and genitourinary spasm (tablets) renalcarematters.com, reviewed

    Kidney dosing: Hyoscine-n-butylbromide (single-agent)
    Show full dosing details
    CrCl ≥60 mL/min
    Tablets: 10 to 20 mg per dose, maximum 60 mg/day. Injection: 10 to 20 mg slowly IV, IM or SC, maximum 100 mg/day (PM).
    CrCl 30–59 mL/min
    The prescribing information gives no kidney dosing. Tablets: negligible absorption, kidney accumulation unlikely. Injection: about half of an intravenous dose is excreted unchanged in urine; use the lowest dose and watch for anticholinergic effects.
    CrCl 15–29 mL/min
    The prescribing information gives no kidney dosing. Tablets: negligible absorption, kidney accumulation unlikely. Injection: about half of an intravenous dose is excreted unchanged in urine; use the lowest dose and watch for anticholinergic effects.
    CrCl <15 mL/min (not on dialysis)
    The prescribing information gives no kidney dosing. Tablets: negligible absorption, kidney accumulation unlikely. Injection: about half of an intravenous dose is excreted unchanged in urine; use the lowest dose and watch for anticholinergic effects.
    Hemodialysis (intermittent)
    Not studied in dialysis; no dose given.
    Peritoneal dialysis
    Not studied in dialysis; no dose given.
    CRRT
    Not studied in dialysis; no dose given.
    • Dialyzable? Not stated.
    • Monitoring Anticholinergic effects: urinary retention, tachycardia, hypotension after injection (observe; emergency equipment available), raised intraocular pressure (urgent review for painful red eye). Avoid IM injection in anticoagulated patients (PM).

    From the Hyoscine-n-butylbromide monograph (renalcarematters.com, reviewed).

  • Use: Uses temporarily relieves minor aches and pains due to: the common cold headache backache minor pain of arthritis toothache muscular aches premenstrual and menstrual cramps temporarily reduces fever US FDA label

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Film-coated tablet: 10 mg/500 mg, 500 mg/10 mg
  • Tablet: 500 mg/10 mg

Registered products in the Philippines

13 products registered with the Food and Drug Administration (FDA) Philippines list Hyoscine-n-butylbromide + Paracetamol as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Also registered under: Paracetamol + Hysocine N-Butylbromide (1 product). Products registered under these spellings are included in the table and marked.

Verify on PH FDA portal

All registered products13
Philippine FDA-registered products for Hyoscine-n-butylbromide + Paracetamol
Package insert
Buscopan PlusHyoscine N-Butylbromide+Paracetamol
10 mg/500 mg Film-Coated TabletAluminum Strip Foil x 4's (Box of 4's and 100's); Aluminum Strip Foil of 25 packs of 4's (Box of 100's); Aluminum Strip Foil of 4's [Box of 4's x 25 packs and Box of 100's, 5 Boxes x 4 Tablets (Shelf-ready box)]
Rx
Sanofi Vietnam Shareholding CompanyVietnam
Importer: Opella Healthcare Philippines, Inc.
DRP-3039
May 31, 2031
Butasine PlusHyoscine-N-Butylbromide+ Paracetamol
10 mg/500 mg Film-Coated TabletAlu/Clear PVDC Blister Pack x 10's Box of 10's, 30's and 100's
Rx
Sai Mirra Innopharm Pvt. Ltd.India
Eon Pharmatek Inc.Trader: Subira Pharmaceuticals Pvt. Ltd.
DRP-9634
Apr 16, 2031
HNBBGEN PlusHyoscine N-Butylbromide + Paracetamol
10 mg/500 mg Film-Coated TabletAlu-Strip Foil Pack x 4's (Box of 100's)
OTC
Azarias Pharmaceutical Laboratories Inc.Philippines
Eba Generisch Trading Inc.
DRP-8641-02
Jan 23, 2030
Hyo-VeraHyoscine N-Butylbromide + Paracetamol
10 mg/500 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
OTC
Genom Biotech Pvt. Ltd.India
TGP Pharma Inc.Importer: Nelpa Lifesciences, Inc.
DRP-17111-01
Oct 1, 2030
Hyodon-PlusParacetamol + Hyoscine N-Butylbromide
500 mg/10 mg TabletAlu-PVC Blister Pack x 10’s (Box of 100’s)
OTC
Hebei Tiancheng Pharmaceutical Co., LtdChina
Importer: AMB HK Enterprises Inc.
DRP-19129
Nov 4, 2031
Hyosaph-PlusHyoscine N-Butylbromide + Paracetamol
10 mg/500 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
OTC
Genom Biotech Pvt. Ltd.India
Nelpa Lifesciences, Inc.
DRP-17111
Oct 1, 2030
Hyosin PlusHyoscine N-Butylbromide + Paracetamol
10 mg/500 mg Film-Coated TabletAlu-Strip Foil Pack x 4's (Box of 100's)
OTC
Azarias Pharmaceutical Laboratories Inc.Philippines
Konzept Convenience and Drug Store Corp.
DRP-8641-03
Jan 23, 2030
HyosphenParacetamol + Hysocine N-ButylbromideVariant spelling
500 mg/10 mg Film-Coated TabletStrip Foil x 10's (Box of 100's)
Rx
Drugmaker's Laboratories, Inc.Philippines
—
DRP-10520
Oct 8, 2031
MaskontrakHyoscine N-Butylbromide + Paracetamol
10mg/500mg Film-Coated TabletAlu-Strip Foil Pack x 4's (Box of 100's)
OTC
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-8641-01
Jan 23, 2030
ParacineParacetamol + Hyoscine N-Butylbromide
500 mg/10 mg Film-Coated TabletAlu/ PVC Blister Pack of 10’s (Box of 100's)
OTC
Azine Healthcare Pvt. Ltd.India
Biophil Medical Equipment And Supplies Trading
DRP-18992
Oct 14, 2031
TeracynParacetamol + Hyoscine N-Butylbromide
500 mg/ 10 mg Film-Coated TabletPlain Strip Foil x 10's (Box of 100's)
OTC
Drugmaker's Laboratories, Inc.Laguna
Terramedic, Inc.
DRP-10520-01
Oct 8, 2031
UniganParacetamol + Hyoscine N-Butylbromide
500 mg/10 mg Film-Coated TabletAlu/Alu Blister pack x 10's (Box of 100's)
Rx
Unison Laboratories Co., Ltd.Thailand
JustRight Healthcare Inc.
DR-XY46748
Oct 15, 2031
Zolnex PlusHyoscine N-Butylbromide + Paracetamol
10 mg/500 mg Film-Coated TabletAlu-Strip Foil Pack x 4's Box of 100's
Rx
Azarias Pharmaceutical Laboratories Inc.Philippines
—
DRP-8641
Jan 23, 2030

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .